诺卡菌感染患者的临床特征、病原学特点及预后分析OA
Clinical characteristics,pathogenic features,and prognosis analysis of patients with Nocardia infection
目的 分析诺卡菌感染患者的临床特征、病原学特点及预后,为诺卡菌感染的临床治疗提供指导.方法 收集35 例诺卡菌感染患者的临床资料,包括一般资料、临床特征、影像学、实验室检查、病原学、治疗方法及预后.计算不同种诺卡菌对各种抗菌药物的耐药率,组间比较采用单因素方差分析和非参数检验进行统计学分析.结果 35 例诺卡菌感染患者中,32 例伴糖皮质激素和免疫抑制剂使用史,伴自身免疫病 9 例,伴呼吸系统疾病 29 例.31 例出现肺部感染,主要表现为发热、咳嗽、咳痰、气促等呼吸道感染症状.胸部CT检查多见结节灶、斑片状密度影、空洞、胸腔积液等.多数患者的白细胞及中性粒细胞、血沉、降钙素原有不同程度升高.35 例诺卡菌包括盖尔森基兴诺卡菌 14 例、鼻疽诺卡菌7 例、脓肿诺卡菌6 例和豚鼠耳炎诺卡菌5 例.药敏试验结果表明,豚鼠耳炎诺卡菌对亚胺培南、复方新诺明、头孢噻肟、环丙沙星、阿莫西林/克拉维酸钾的耐药率较高,分别为40%、40%、100%、40%和40%;鼻疽诺卡菌对头孢噻肟的耐药率较高,为57.1%;盖尔森基兴诺卡菌对阿莫西林/克拉维酸钾的耐药率为 100%;巴西诺卡菌对头孢噻肟和环丙沙星的耐药率为 100%;华莱士诺卡菌和达松维尔拟诺卡菌的敏感率均为 100%.治疗上单用磺胺类 1 例,21 例以磺胺类为基础联合治疗.4 例病情恶化后自动出院或死亡,31 例均好转出院.结论 诺卡菌感染患者好发于免疫功能低下人群,受累部位主要为肺部、皮肤软组织和血液系统,临床症状、影像学及实验室检查缺乏相关特异性.早期识别和有效的抗感染治疗是改善诺卡菌感染患者预后的关键.
Objective To analyze the clinical characteristics,pathogenic features,and prognosis of patients with Nocardia infection,and provide guidance for the clinical treatment of Nocardia infection.Methods Clinical data of 35 patients with No-cardia infection were collected,including general information,clinical characteristics,imaging,laboratory tests,etiology,treat-ment methods,and prognosis.The resistance rates of different Nocardia species to various antimicrobial agents were calculated.Intergroup comparisons were performed using one-way ANOVA and non-parametric tests for statistical analysis.Results Among 35 patients with Nocardia infection,32 had a history of glucocorticoid and immunosuppressant use;9 had autoimmune diseases,and 29 had respiratory system diseases.Pulmonary infection occurred in 31 cases,mainly manifested as respiratory tract infection symptoms such as fever,cough,sputum production,and shortness of breath.Chest CT examinations frequently showed nodules,patchy opacities,cavities,and pleural effusion.The majority of patients had elevated white blood cell and neutrophil counts,e-rythrocyte sedimentation rate,and procalcitonin to varying degrees.The 35 Nocardia strains included 14 Nocardia cyriacigeorgi-ca,7 Nocardia farcinica,6 Nocardia abscessus,and 5 Nocardia otitidiscaviarum.Drug susceptibility testing results showed that Nocardia otitidiscaviarum had high resistance rates to imipenem,trimethoprim-sulfamethoxazole,cefotaxime,ciprofloxacin,and amoxicillin/clavulanate potassium at 40%,40%,100%,40%,and 40%,respectively;Nocardia farcinica had a high resist-ance rate to cefotaxime at 57.1%;Nocardia cyriacigeorgica had a resistance rate of 100%to amoxicillin/clavulanate potassium;Nocardia brasiliensis had resistance rates of 100%to both cefotaxime and ciprofloxacin;Nocardia wallacei and Nocardia dasson-villei both showed 100%susceptibility rates.Regarding treatment,1 patient received sulfonamide monotherapy,and 21 patients received combination therapy with sulfonamides as the foundation.Four patients experienced disease progression and were dis-charged against medical advice or died,while 31 patients improved and were discharged.Conclusion Nocardia infection is more common in the immunocompromised individuals,mainly affecting the lungs,skin and soft tissues,and blood system.Clinical symptoms,imaging,and laboratory tests lack specificity.Early identification and effective anti-infective treatment are key to im-proving the prognosis of patients with Nocardia nfection.
路秀芳;田金静;康亚丽;刘敬平;李霞;刘琳
聊城市第二人民医院检验科 山东 聊城 252600聊城市第二人民医院检验科 山东 聊城 252600聊城市第二人民医院检验科 山东 聊城 252600聊城市第二人民医院检验科 山东 聊城 252600聊城市第二人民医院风湿免疫科 山东 聊城 252600聊城市第二人民医院检验科 山东 聊城 252600
医药卫生
诺卡菌感染临床特征诺卡菌分型耐药率治疗及预后
Nocardia infectionclinical featureNocardia typingdrug resistance ratetreatment and prognosis
《滨州医学院学报》 2026 (2)
179-183,5
山东省医药卫生科技发展计划面上项目(202211000916)
评论